Catherine Wood's GENB Position Overview
Catherine Wood (via Ark Investment Management LLC) currently holds 1.28 M shares of Generate Biomedicines, Inc. (GENB) worth $21.67 M, representing 0.14% of the portfolio. First purchased in 2026-Q1, this recently established position has been held for 2 quarters.
Based on recent 13F filings, Catherine Wood has initiated a new position in GENB, representing a fresh investment thesis on this company. Largest addition occurred in Q2 2026, adding 786,209 shares.
Analysis based on 13F filings available since 2013 Q2
Catherine Wood's Generate Biomedicines (GENB) Holding Value Over Time
Track share changes against reported price movement
Quarterly Generate Biomedicines (GENB) Trades by Catherine Wood
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +786,209 | Add 157.74% | 1.28 M | $16.87 |
| Q1 2026 | +498,408 | New Buy | 498,408 | $12.50 |
Catherine Wood's Generate Biomedicines Investment FAQs
Catherine Wood first purchased Generate Biomedicines, Inc. (GENB) in Q1 2026, acquiring 498,408 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Catherine Wood has held Generate Biomedicines, Inc. (GENB) for 2 quarters since Q1 2026.
Catherine Wood's largest addition to Generate Biomedicines, Inc. (GENB) was in Q2 2026, adding 1,284,617 shares worth $21.67 M.
According to the latest 13F filing for Q2 2026, Catherine Wood's firm, Ark Investment Management LLC, owns 1,284,617 shares of Generate Biomedicines, Inc. (GENB), valued at approximately $21.67 M.
As of the Q2 2026 filing, Generate Biomedicines, Inc. (GENB) represents approximately 0.14% of Catherine Wood's publicly disclosed stock portfolio, making it one of their key holdings.
Catherine Wood's peak holding in Generate Biomedicines, Inc. (GENB) was 1,284,617 shares, as reported at the end of Q2 2026.